Polysaccharide conjugate vaccine protein carriers as a “neglected valency” - Potential and limitations

Article ID	Journal	Published Year	Pages	File Type
5537464	Vaccine	2017	9 Pages	PDF

Keywords

MenY Tetanus-diphtheria PCV13 PspA MENA NTHi EPA menB PCV7 PHiD-CV Tdap PPV23 DTwP DTaP IPV PhtD RCT dPly GBS CRM GMC IgG MenACWY AOM Non-typeable Haemophilus influenzae OmpC Randomized controlled trial immunoglobulin A immunoglobulin G IgA ITT diphtheria toxoid tetanus toxoid Protein carriers per protocol acute otitis media confidence interval Intent-to-treat Menc Geometric mean concentration Haemophilus influenzae type b Hib 7-valent pneumococcal conjugate vaccine Pneumococcal conjugate vaccine 23-Valent pneumococcal polysaccharide vaccine 13-Valent pneumococcal conjugate vaccine PCV یا Pneumococcal conjugate vaccine inactivated poliovirus Pneumococcal surface protein A group B Streptococcus

Related Topics

Life Sciences Immunology and Microbiology Immunology

Polysaccharide conjugate vaccine protein carriers as a “neglected valency” - Potential and limitations

Authors

Michael Bröker, Francesco Berti, Joerg Schneider, Ivo Vojtek,